mRNA specialist BioNTech has chalked up an important win in its cancer pipeline, showing efficacy with its BNT111 vaccine candidate in a phase 2 trial in advanced melanoma. The study is looking at the ...
In another major setback for abortion care in the US, a US court has issued an order restricting the distribution of ...
Axsome Therapeutics' Auvelity has become the first non-antipsychotic therapy for agitation in patients with Alzheimer's ...
In its first meeting for months, the FDA's Oncologic Drugs Advisory Committee (ODAC) voted against AstraZeneca's oral ...
Moderna saw its first-quarter revenues nearly triple to $389 million compared to the same period of 2025, with international ...
Contract research organisation Parexel has bought Vitrana and its AI-powered pharmacovigilance platform for an undisclosed ...
In a statement, Prime Minister Keir Starmer said the "significant investment" had been "made possible by the pharmaceutical ...
Intellia Therapeutics has reported the first-ever phase 3 results with an in vivo gene-editing therapy, hereditary angioedema ...
For years, conversations about artificial intelligence (AI) in life sciences have alternated between hype and hesitation.
Avalyn Pharma has priced its initial public offering (IPO) on the Nasdaq, hoping to raise an upscaled $300 million for its ...
From chip giant NVIDIA agreeing a $2 billion partnership with AI cloud provider Nebius, to Roche ramping up its investment in ...
In addition to the three NPVs, the FDA also announced the approval of an IND submission for DemeRx, which is investigating ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results